Skip to main content
. 2016 May 15;7(24):36909–36923. doi: 10.18632/oncotarget.9377

Figure 1. miR-129-2 is frequently downregulated in HCC tissues and is negatively associated with metastatic potential.

Figure 1

(A, B) Relative miR-129-2 expression levels in 106 paired HCC tissues and matched adjacent normal tissues were determined by qRT-PCR. (C) Comparison of miR-129-2 expression in 20 paired tumor tissues and the corresponding portal vein tumor thrombus (PVTT) by qRT-PCR. (D) Comparison of miR-129-2 expression in HCC tissues arising from recurrent and non-recurrent groups by qRT-PCR. (E) Comparison of miR-129-2 in differentiated (metastatic potential) HCC tissues was analyzed. (F) The expression of miR-129-2 in five HCC cell lines was significantly decreased compared with that in the LO2 cells. U6 snRNA was used as internal control. *P < 0.05, **P < 0.01.